CLINICAL STAGE III CUTANEOUS MERKEL CELL CARCINOMA AJCC V8
Clinical trials for CLINICAL STAGE III CUTANEOUS MERKEL CELL CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE III CUTANEOUS MERKEL CELL CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE III CUTANEOUS MERKEL CELL CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Dual attack: fighting cancer while protecting a transplanted kidney
Disease control Recruiting nowThis study is testing a new treatment approach for people who have had a kidney transplant and now have advanced skin cancer that cannot be removed by surgery or has spread. The goal is to see if a combination of cancer immunotherapy drugs (nivolumab and ipilimumab) can be given …
Matched conditions: CLINICAL STAGE III CUTANEOUS MERKEL CELL CARCINOMA AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Insurance red tape slows skin cancer care, study finds
Knowledge-focused Recruiting nowThis study aims to understand how insurance delays affect patients with advanced skin cancers who need treatment before surgery. Researchers will follow 70 patients to track the time and costs involved in getting insurance approval for both standard and off-label drug treatments.…
Matched conditions: CLINICAL STAGE III CUTANEOUS MERKEL CELL CARCINOMA AJCC V8
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC